Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Design of Multivalent Inhibitors for Preventing Cellular Uptake

V. Schubertová, FJ. Martinez-Veracoechea, R. Vácha,

. 2017 ; 7 (1) : 11689. [pub] 20170915

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Cellular entry, the first crucial step of viral infection, can be inhibited by molecules adsorbed on the virus surface. However, apart from using stronger affinity, little is known about the properties of such inhibitors that could increase their effectiveness. Our simulations showed that multivalent inhibitors can be designed to be much more efficient than their monovalent counterparts. For example, for our particular simulation model, a single multivalent inhibitor spanning 5 to 6 binding sites is enough to prevent the uptake compared to the required 1/3 of all the receptor binding sites needed to be blocked by monovalent inhibitors. Interestingly, multivalent inhibitors are more efficient in inhibiting the uptake not only due to their increased affinity but mainly due to the co-localization of the inhibited receptor binding sites at the virion's surface. Furthermore, we show that Janus-like inhibitors do not induce virus aggregation. Our findings may be generalized to other uptake processes including bacteria and drug-delivery.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035581
003      
CZ-PrNML
005      
20191008113050.0
007      
ta
008      
191007s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-017-11735-7 $2 doi
035    __
$a (PubMed)28916832
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Schubertová, Veronika $u Faculty of Science, Masaryk University, Brno, Czech Republic. Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
245    10
$a Design of Multivalent Inhibitors for Preventing Cellular Uptake / $c V. Schubertová, FJ. Martinez-Veracoechea, R. Vácha,
520    9_
$a Cellular entry, the first crucial step of viral infection, can be inhibited by molecules adsorbed on the virus surface. However, apart from using stronger affinity, little is known about the properties of such inhibitors that could increase their effectiveness. Our simulations showed that multivalent inhibitors can be designed to be much more efficient than their monovalent counterparts. For example, for our particular simulation model, a single multivalent inhibitor spanning 5 to 6 binding sites is enough to prevent the uptake compared to the required 1/3 of all the receptor binding sites needed to be blocked by monovalent inhibitors. Interestingly, multivalent inhibitors are more efficient in inhibiting the uptake not only due to their increased affinity but mainly due to the co-localization of the inhibited receptor binding sites at the virion's surface. Furthermore, we show that Janus-like inhibitors do not induce virus aggregation. Our findings may be generalized to other uptake processes including bacteria and drug-delivery.
650    _2
$a antivirové látky $x chemie $x farmakologie $7 D000998
650    12
$a racionální návrh léčiv $7 D015195
650    _2
$a simulace molekulární dynamiky $7 D056004
650    _2
$a internalizace viru $x účinky léků $7 D053586
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Martinez-Veracoechea, Francisco J $u Eesti Energia AS, Lelle 22, 11318, Tallinn, Estonia.
700    1_
$a Vácha, Robert $u Faculty of Science, Masaryk University, Brno, Czech Republic. robert.vacha@mail.muni.cz. Central European Institute of Technology, Masaryk University, Brno, Czech Republic. robert.vacha@mail.muni.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 11689
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28916832 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008113506 $b ABA008
999    __
$a ok $b bmc $g 1452241 $s 1074131
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 1 $d 11689 $e 20170915 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...